Skip to main content

Table 4 Day 42 treatment success rate of artemisinin combination therapies among P. falciparum patients

From: Efficacy and safety of artemisinin-based combination therapies for the treatment of uncomplicated malaria in pediatrics: a systematic review and meta-analysis

Author Country Design Age Drugs Day 42 ACPR (n/N, %)
Davlantes 2018 [25] Angola Non-RCT < 12 years DP 169/169, 100%
Plucinski 2017 [35] Angola Non-RCT 6 m to 12 years DP 144/145, 99.3%
Premji 2009 [36] Burkina Faso, Ghana, Kenya, Nigeria, Tanzania RCT, phase III trial 1 to 15 years CDA 697/771, 90.4%
AL 358/384, 93.2%
Ramharter 2008 [37] Gabon Non-RCT 2–14 years AP 9:3-mg/kg tabs 8/9, 88.9%
AP 9:3-mg/kg granule 13/14, 92.9%
Sawa 2013 [38] Kenya RCT 6 months to 10 years AL 115/119, 96.6%
DP 129/129, 100%
Total      1633/1740, 93.9%